|
1
|
Weller M, van den Bent M, Hopkins K, Tonn
JC, Stupp R, Falini A, Cohen-Jonathan-Moyal E, Frappaz D,
Henriksson R, Balana C, et al: EANO guideline for the diagnosis and
treatment of anaplastic gliomas and glioblastoma. Lancet Oncol.
15:e395–e403. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thakkar JP, Dolecek TA, Horbinski C,
Ostrom QT, Lightner DD, Barnholtz-Sloan JS and Villano JL:
Epidemiologic and molecular prognostic review of glioblastoma.
Cancer Epidemiol Biomarkers Prev. 23:1985–1996. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ostrom QT, Gittleman H, Stetson L, Virk SM
and Barnholtz-Sloan JS: Epidemiology of gliomas. Cancer Treat Res.
163:1–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Omuro A and DeAngelis LM: Glioblastoma and
other malignant gliomas: A clinical review. JAMA. 310:1842–1850.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li N, Wang L, Tan G, Guo Z, Liu L, Yang M
and He J: MicroRNA-218 inhibits proliferation and invasion in
ovarian cancer by targeting Runx2. Oncotarget. 8:91530–91541.
2017.PubMed/NCBI
|
|
6
|
Shi D and Zhang Y, Lu R and Zhang Y: The
long non-coding RNA MALAT1 interacted with miR-218 modulates
choriocarcinoma growth by targeting Fbxw8. Biomed Pharmacother.
97:543–550. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mohr AM and Mott JL: Overview of microRNA
biology. Semin Liver Dis. 35:3–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hammond SM: An overview of microRNAs. Adv
Drug Deliv Rev. 87:3–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen P, Zhao Y and Li Y: MiR-218 inhibits
migration and invasion of lung cancer cell by regulating Robo1
expression. Zhongguo Fei Ai Za Zhi. 20:452–458. 2017.(In Chinese).
PubMed/NCBI
|
|
10
|
Bao ZS, Li MY, Wang JY, Zhang CB, Wang HJ,
Yan W, Liu YW, Zhang W, Chen L and Jiang T: Prognostic value of a
nine-gene signature in glioma patients based on mRNA expression
profiling. CNS Neurosci Ther. 20:112–118. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen W, Yu Q, Chen B, Lu X and Li Q: The
prognostic value of a seven-microRNA classifier as a novel
biomarker for the prediction and detection of recurrence in glioma
patients. Oncotarget. 7:53392–53413. 2016.PubMed/NCBI
|
|
12
|
Yang Y, Ding L, Hu Q, Xia J, Sun J, Wang
X, Xiong H, Gurbani D, Li L, Liu Y and Liu A: MicroRNA-218
functions as a tumor suppressor in lung cancer by targeting
IL-6/STAT3 and negatively correlates with poor prognosis. Mol
Cancer. 16:1412017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cheng MW, Wang LL and Hu GY: Expression of
microRNA-218 and its clinicopathological and prognostic
significance in human glioma cases. Asian Pac J Cancer Prev.
16:1839–1843. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mobahat M, Narendran A and Riabowol K:
Survivin as a preferential target for cancer therapy. Int J Mol
Sci. 15:2494–2516. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jaskoll T, Chen H, Min Zhou Y, Wu D and
Melnick M: Developmental expression of survivin during embryonic
submandibular salivary gland development. BMC Dev Biol. 1:52001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Conde M, Michen S, Wiedemuth R, Klink B,
Schröck E, Schackert G and Temme A: Chromosomal instability induced
by increased BIRC5/Survivin levels affects tumorigenicity of glioma
cells. BMC Cancer. 17:8892017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sheng L, Wan B, Feng P, Sun J, Rigo F,
Bennett CF, Akerman M, Krainer AR and Hua Y: Downregulation of
Survivin contributes to cell-cycle arrest during postnatal cardiac
development in a severe spinal muscular atrophy mouse model. Hum
Mol Genet. 27:486–498. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yoshikawa K, Shimada M, Higashijima J,
Nakao T, Nishi M, Takasu C, Kashihara H, Eto S and Bando Y: Ki-67
and survivin as predictive factors for rectal cancer treated with
preoperative chemoradiotherapy. Anticancer Res. 38:1735–1739.
2018.PubMed/NCBI
|
|
19
|
Li PL, Zhang X, Wang LL, Du LT, Yang YM,
Li J and Wang CX: MicroRNA-218 is a prognostic indicator in
colorectal cancer and enhances 5-fluorouracil-induced apoptosis by
targeting BIRC5. Carcinogenesis. 36:1484–1493. 2015.PubMed/NCBI
|
|
20
|
Kogo R, How C, Chaudary N, Bruce J, Shi W,
Hill RP, Zahedi P, Yip KW and Liu FF: The microRNA-218~Survivin
axis regulates migration, invasion, and lymph node metastasis in
cervical cancer. Oncotarget. 6:1090–1100. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu Y, Xu K and Yagüe E: miR-218 targets
survivin and regulates resistance to chemotherapeutics in breast
cancer. Breast Cancer Res Treat. 151:269–280. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ishiyama M, Miyazono Y, Sasamoto K, Ohkura
Y and Ueno K: A highly water-soluble disulfonated tetrazolium salt
as a chromogenic indicator for NADH as well as cell viability.
Talanta. 44:1299–1305. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun Y, Zhang Y and Chi P: Pirfenidone
suppresses TGF-β1-induced human intestinal fibroblasts activities
by regulating proliferation and apoptosis via the inhibition of the
Smad and PI3K/AKT signaling pathway. Mol Med Rep. 18:3907–3913.
2018.PubMed/NCBI
|
|
25
|
Dai Z, Wu J, Chen F, Cheng Q, Zhang M,
Wang Y, Guo Y and Song T: CXCL5 promotes the proliferation and
migration of glioma cells in autocrine- and paracrine-dependent
manners. Oncol Rep. 36:3303–3310. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang T, Shao Y, Chu TY, Huang HS, Liou
YL, Li Q and Zhou H: MiR-135a and MRP1 play pivotal roles in the
selective lethality of phenethyl isothiocyanate to malignant glioma
cells. Am J Cancer Res. 6:957–972. 2016.PubMed/NCBI
|
|
27
|
Lechler P, Renkawitz T, Campean V,
Balakrishnan S, Tingart M, Grifka J and Schaumburger J: The
antiapoptotic gene survivin is highly expressed in human
chondrosarcoma and promotes drug resistance in chondrosarcoma cells
in vitro. BMC Cancer. 11:1202011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao G, Wang Q, Gu Q, Qiang W, Wei JJ,
Dong P, Watari H, Li W and Yue J: Lentiviral CRISPR/Cas9 nickase
vector mediated BIRC5 editing inhibits epithelial to mesenchymal
transition in ovarian cancer cells. Oncotarget. 8:94666–94680.
2017.PubMed/NCBI
|
|
29
|
Slattery ML, Mullany LE, Sakoda LC, Wolff
RK, Samowitz WS and Herrick JS: Dysregulated genes and miRNAs in
the apoptosis pathway in colorectal cancer patients. Apoptosis.
23:237–250. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jingjing L, Wangyue W, Qiaoqiao X and
Jietong Y: MiR-218 increases sensitivity to cisplatin in esophageal
cancer cells via targeting survivin expression. Open Med (Wars).
11:31–35. 2016.PubMed/NCBI
|
|
31
|
Zarogoulidis P, Petanidis S, Kioseoglou E,
Domvri K, Anestakis D and Zarogoulidis K: MiR-205 and miR-218
expression is associated with carboplatin chemoresistance and
regulation of apoptosis via Mcl-1 and Survivin in lung cancer
cells. Cell Signal. 27:1576–1588. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zheng HC: The molecular mechanisms of
chemoresistance in cancers. Oncotarget. 8:59950–59964.
2017.PubMed/NCBI
|
|
33
|
Tu Y, Gao X, Li G, Fu H, Cui D, Liu H, Jin
W and Zhang Y: MicroRNA-218 inhibits glioma invasion, migration,
proliferation, and cancer stem-like cell self-renewal by targeting
the polycomb group gene Bmi1. Cancer Res. 73:6046–6055. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gu JJ, Gao GZ and Zhang SM: miR-218
inhibits the migration and invasion of glioma U87 cells through the
Slit2-Robo1 pathway. Oncol Lett. 9:1561–1566. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xia H, Yan Y, Hu M, Wang Y, Wang Y, Dai Y,
Chen J, Di G, Chen X and Jiang X: MiR-218 sensitizes glioma cells
to apoptosis and inhibits tumorigenicity by regulating
ECOP-mediated suppression of NF-κB activity. Neuro Oncol.
15:413–422. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu J, Xu W and Zhu J: Propofol suppresses
proliferation and invasion of glioma cells by upregulating
microRNA-218 expression. Mol Med Rep. 12:4815–4820. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gao X and Jin W: The emerging role of
tumor-suppressive microRNA-218 in targeting glioblastoma stemness.
Cancer Lett. 353:25–31. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Alajez NM, Lenarduzzi M, Ito E, Hui AB,
Shi W, Bruce J, Yue S, Huang SH, Xu W, Waldron J, et al: MiR-218
suppresses nasopharyngeal cancer progression through downregulation
of survivin and the SLIT2-ROBO1 pathway. Cancer Res. 71:2381–2391.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang X, Zhang C, Guo T, Feng Y, Liu Q,
Chen Y and Zhang Q: Reduced expression of microRNA206 regulates
cell proliferation via cyclinD2 in gliomas. Mol Med Rep.
11:3295–3300. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang H, Wang Y, Bao Z, Zhang C, Liu Y, Cai
J and Jiang C: Hypomethylated Rab27b is a progression-associated
prognostic biomarker of glioma regulating MMP-9 to promote
invasion. Oncol Rep. 34:1503–1509. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu Y, Tang K, Yan W, Wang Y, You G, Kang
C, Jiang T and Zhang W: Identifying Ki-67 specific miRNA-mRNA
interactions in malignant astrocytomas. Neurosci Lett. 546:36–41.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhou GS, Song LJ and Yang B:
Isoliquiritigenin inhibits proliferation and induces apoptosis of
U87 human glioma cells in vitro. Mol Med Rep. 7:531–536.
2013. View Article : Google Scholar : PubMed/NCBI
|
